Literature DB >> 31619525

Evaluation of OMNIgene Sputum and Ethanol Reagent for Preservation of Sputum Prior to Xpert and Culture Testing in Uganda.

Elisa Ardizzoni1, Patrick Orikiriza2,3,4, Charles Ssuuna4, Dan Nyehangane5, Mourad Gumsboga6, Ivan Mugisha Taremwa5, Esther Turyashemererwa5, Juliet Mwanga-Amumpaire5, Céline Langendorf7, Maryline Bonnet5,3,8.   

Abstract

Xpert MTB/RIF (Xpert) and culture are the most reliable methods for tuberculosis diagnosis but are still poorly accessible in many low-resource countries. We aimed to assess the effects of OMNIgene Sputum (OM-S) and ethanol in preserving sputum for Xpert and OM-S for mycobacterial growth indicator tube (MGIT) testing over periods of 15 and 8 days, respectively. Sputum samples were collected from newly diagnosed smear-positive patients. For Xpert, pooled samples were split into 5 aliquots: 3 for Xpert on days 0, 7, and 15 without additive and 2 with either OM-S or ethanol at day 15. For MGIT, 2 aliquots were tested without preservative and 2 with OM-S at 0 and 8 days. Totals of 48 and 47 samples were included in the analysis for Xpert and culture. With Xpert, using day 0 as a reference, untreated samples stored for 7 and 15 days showed concordances of 45/46 (97.8%) and 46/48 (95.8%). For samples preserved with OM-S or ethanol for 15 days compared with untreated samples processed at day 0 or after 15 days, OM-S concordances were 46/48 (95.8%) and 47/48 (97.9%), while those of ethanol were 44/48 (91.7%) and 45/48 (93.8%). With MGIT, concordances between untreated and OM-S-treated samples were 21/41 (51.2%) at day 0 and 21/44 (47.7%) at day 8. In conclusion, Xpert equally detected tuberculosis in OM-S-treated and untreated samples up to 15 days but showed slightly lower detection in ethanol-treated samples. Among OM-S-treated samples, MGIT positivity was significantly lower than in untreated samples at both time points.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  OMNIgene; Xpert; culture; tuberculosis

Year:  2019        PMID: 31619525      PMCID: PMC6935912          DOI: 10.1128/JCM.00810-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection.

Authors:  J Daniel Kelly; Shou-Yean Grace Lin; Pennan M Barry; Chris Keh; Julie Higashi; John Z Metcalfe
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

2.  Evaluation of OMNIgene®•SPUTUM-stabilised sputum for long-term transport and Xpert® MTB/RIF testing in Nepal.

Authors:  B Maharjan; C D Kelly-Cirino; A Weirich; P S Curry; H Hoffman; K Avsar; B Shrestha
Journal:  Int J Tuberc Lung Dis       Date:  2016-12-01       Impact factor: 2.373

3.  OMNIgene SPUTUM: A good transport and decontaminating reagent for tuberculosis testing.

Authors:  Diana Asema Asandem; Adwoa Asante-Poku; Prince Asare; Sammy Yaw Aboagye; Osei-Wusu Stephen; Emelia Danso; Pius Mawutor Klevor; Kenneth Mawuta Hayibor; Dorothy Yeboah-Manu
Journal:  Int J Mycobacteriol       Date:  2018 Jul-Sep

4.  Novel multi-day sputum transport reagent works with routine tuberculosis tests and eliminates need for cold chain: Preliminary study of compatibility with the Xpert® MTB/RIF assay.

Authors:  Cassandra D Kelly-Cirino; Patricia S Curry; Jamie L Marola; Niels K Helstrom; Max Salfinger
Journal:  Diagn Microbiol Infect Dis       Date:  2016-08-16       Impact factor: 2.803

5.  False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications.

Authors:  A Van Rie; K Mellet; M-A John; L Scott; L Page-Shipp; H Dansey; T Victor; R Warren
Journal:  Int J Tuberc Lung Dis       Date:  2012-02       Impact factor: 2.373

6.  Thymoquinone protects against the sepsis induced mortality, mesenteric hypoperfusion, aortic dysfunction and multiple organ damage in rats.

Authors:  Erdem Kamil Ozer; Mustafa Tugrul Goktas; Aysun Toker; Sultan Pehlivan; Hulagu Bariskaner; Ceyhan Ugurluoglu; Alper Bektas Iskit
Journal:  Pharmacol Rep       Date:  2017-03-24       Impact factor: 3.024

7.  Ethanol fixation of sputum sediments for DNA-based detection of Mycobacterium tuberculosis.

Authors:  D L Williams; T P Gillis; W G Dupree
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

8.  Evaluation of OMNIgene®•SPUTUM reagent for mycobacterial culture.

Authors:  J Zallet; I D Olaru; A-K Witt; P Vock; B Kalsdorf; S Andres; D Hillemann; K Kranzer
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

9.  Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature.

Authors:  Elisa Tagliani; Riccardo Alagna; Silva Tafaj; Hasan Hafizi; Daniela Maria Cirillo
Journal:  BMC Infect Dis       Date:  2017-10-02       Impact factor: 3.090

10.  A novel sputum transport solution eliminates cold chain and supports routine tuberculosis testing in Nepal.

Authors:  Bhagwan Maharjan; Bhabana Shrestha; Alexandra Weirich; Andrew Stewart; Cassandra D Kelly-Cirino
Journal:  J Epidemiol Glob Health       Date:  2016-04-27
View more
  2 in total

1.  Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

Authors:  Adrienne E Shapiro; Jennifer M Ross; Mandy Yao; Ian Schiller; Mikashmi Kohli; Nandini Dendukuri; Karen R Steingart; David J Horne
Journal:  Cochrane Database Syst Rev       Date:  2021-03-23

2.  Viability assessment of Mycobacterium tuberculosis complex in OMNIgene • SPUTUM reagent using the BACTEC MGIT 960 System and Xpert MTB/RIF assay.

Authors:  Akemi Oshiro Guirelli; Andréia Moreira Dos Santos Carmo; André Eterovic; Lucilaine Ferrazoli; Vilma Dos Santos Menezes Gaiotto Daros; Maria Cecilia Cergole-Novella
Journal:  Braz J Microbiol       Date:  2021-08-23       Impact factor: 2.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.